Skip to main content

Fexofenadine Hydrochloride

NDC 45802-847 · Padagis Israel Pharmaceuticals Ltd

Generic namefexofenadine hydrochloride
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)FEXOFENADINE HYDROCHLORIDE
Strength180 mg/1
Pharmacologic classHistamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
Marketing categoryANDA

Packages

45802-847-78 — 1 BOTTLE in 1 CARTON (45802-847-78) / 100 TABLET, FILM COATED in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

41167-4320 — fexofenadine hydrochloride and pseudoephedrine hydrochloride, 41250-506 — Fexofenadine HCl, 41415-995 — fexofenadine hydrochloride and pseudoephedrine hydrochloride, 41520-229 — fexofenadine hcl, 42507-192 — Fexofenadine Hydrochloride, 42507-847 — fexofenadine hydrochloride, 43598-809 — Fexofenadine hydrochloride, 43598-823 — Fexofenadine HCl and Pseudoephedrine HCI, 43598-892 — Fexofenadine HCl and Pseudoephedrine HCl, 43598-936 — Fexofenadine hydrochloride, 46122-452 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 46122-694 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 46122-779 — FEXOFENADINE HYDROCHLORIDE, 47335-724 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 49035-208 — Fexofenadine HCL, 49035-366 — fexofenadine hydrochloride, 50090-1203 — fexofenadine hydrochloride and pseudoephedrine hydrochloride, 50090-1234 — fexofenadine hydrochloride, 50090-4070 — Fexofenadine HCL, 50090-4267 — Fexofenadine HCL, +225 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels